KCNA3 and cancer: In collaboration with the groups of Professors Gulbins and Kalthoff, we have recently demonstrated that pharmacological targeting of a mitochondrial K+ channel, namely of Kv1.3 of the shaker family (mitoKv1.3), efficiently triggers programmed cell death (18) and provides a new tool to selectively eliminate cancer cells even in vivo (19, 20).